C
Cordula Petersen
Researcher at University of Hamburg
Publications - 193
Citations - 5028
Cordula Petersen is an academic researcher from University of Hamburg. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 37, co-authored 171 publications receiving 4157 citations. Previous affiliations of Cordula Petersen include Dresden University of Technology.
Papers
More filters
Journal ArticleDOI
HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity.
Thorsten Rieckmann,Silke Tribius,Tobias Grob,Felix Meyer,Chia-Jung Busch,Cordula Petersen,Ekkehard Dikomey,Malte Kriegs +7 more
TL;DR: Increased cellular radiosensitivity due to compromised DNA repair capacity is likely to contribute to the improved outcome of patients with HPV/p16(INK4a)-positive tumors when treated by radiotherapy.
Journal ArticleDOI
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer
Maaike H. M. Oonk,François Planchamp,Peter Baldwin,Mariusz Bidziński,Mats Brännström,Fabio Landoni,Sven Mahner,Umesh Mahantshetty,Mansoor Raza Mirza,Cordula Petersen,Denis Querleu,Sigrid Regauer,Lukas Rob,Roman Rouzier,Elena Ulrikh,Jacobus van der Velden,Ignace Vergote,Linn Woelber,Ate G.J. van der Zee +18 more
TL;DR: Developing clinically relevant and evidence-based guidelines to improve the quality of care for women with gynecologic cancers across Europe based on the best available evidence and expert agreement is published.
Journal ArticleDOI
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Juliane Rieber,Jan Streblow,Lorenz Uhlmann,Michael Flentje,Marciana Nona Duma,Iris Ernst,Oliver Blanck,Andrea Wittig,Judit Boda-Heggemann,Robert Krempien,Fabian Lohaus,N. D. Klass,Michael J. Eble,Detlef Imhoff,H. Kahl,Cordula Petersen,Sabine Gerum,Christoph Henkenberens,Sonja Adebahr,Peter Hass,E. Schrade,Thomas G. Wendt,Guido Hildebrandt,Nicolaus Andratschke,Florian Sterzing,Matthias Guckenberger,Matthias Guckenberger +26 more
TL;DR: SBRT for medically inoperable patients with pulmonary metastases achieved excellent local control and promising overall survival and important prognostic factors were identified for selecting patients who might benefit most from this therapy approach.
Journal ArticleDOI
[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes.
TL;DR: FEC-PET/CT planning could be helpful in dose escalation to lymph nodal sites of prostate cancer, and in conjunction with intensity modulated radiotherapy (IMRT) and imaged guided radi therapy (IGRT), it might offer the opportunity of dose escalationto selected sites while avoiding unnecessary irradiation of healthy tissues.
Journal ArticleDOI
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases
N. Andratschke,H. Alheid,Michael Allgäuer,Gerhild Becker,Oliver Blanck,Judit Boda-Heggemann,Thomas B. Brunner,Marciana-Nona Duma,Sabine Gerum,Matthias Guckenberger,Guido Hildebrandt,Rainer J. Klement,V. Lewitzki,C. Ostheimer,Alexandros Papachristofilou,Cordula Petersen,Thomas Schneider,Robert Semrau,Stefan Wachter,Daniel Habermehl +19 more
TL;DR: After an initial learning curve with regards to total cumulative doses, consistently high biologically effective doses have been employed translating into high local tumor control at 1 and 2 years and overall survival is mainly influenced by histology and metastatic tumor burden.